Download PDF

1. Company Snapshot

1.a. Company Description

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally.It operates in two segments, Surgical and Woundcare.The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand.


The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand.Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.

Show Full description

1.b. Last Insights on AMS

Advanced Medical Solutions Group's recent performance was negatively impacted by conservative accounting practices, which may have contributed to weak earnings. The company's cautious approach to revenue recognition and expense management has raised concerns among investors. Additionally, the UK market's downturn, driven by weak trade data from China, has created a challenging environment for the company to operate in. Furthermore, the lack of recent earnings releases or significant news events has contributed to the negative sentiment surrounding the company.

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Card image cap

UK Stocks Estimated To Be Trading Below Their Intrinsic Value

Dec -02

Source:

Card image cap

UK Stocks That May Be Trading Below Estimated Value In November 2025

Nov -27

Source:

Card image cap

Discover 3 UK Stocks Estimated To Be Up To 48.7% Below Their Intrinsic Value

Nov -26

Source:

Card image cap

UK's Elite Stocks Priced Below Estimated Value In November 2025

Nov -25

Source:

Card image cap

UK Market: Unveiling 3 Stocks That May Be Trading Below Estimated Value

Nov -24

Source:

Card image cap

UK Value Stocks Trading At Estimated Discounts

Nov -19

Source:

Card image cap

UK's Intriguing Trio: ACG Metals and Two Stocks Estimated Below Fair Value

Nov -17

Source:

Card image cap

3 UK Stocks Estimated To Be Trading At Discounts Of Up To 40.3%

Nov -14

Source:

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (8.71%)

6. Segments

Surgical

Expected Growth: 8.85%

Advanced Medical Solutions Group plc's Surgical segment growth of 8.85% is driven by increasing demand for wound care and surgical products, expansion into new markets, and strategic partnerships. Additionally, the company's focus on innovation, product development, and cost savings initiatives have contributed to the segment's growth.

Woundcare

Expected Growth: 8.5%

AMS's Woundcare segment growth is driven by increasing adoption of its innovative LiquiBand fixative and ActivHeal dressings, expanding into new geographies, and rising demand for advanced wound care products. Additionally, the growing prevalence of chronic wounds, aging population, and increasing healthcare expenditure are contributing to the 8.5% growth.

7. Detailed Products

LiquiBand

A range of topical wound adhesives used to close and protect wounds, including skin lesions, lacerations, and surgical incisions.

LiquiBand Fix 8

A sterile, single-use, topical wound adhesive used to close and protect wounds, including skin lesions, lacerations, and surgical incisions.

ActivHeal

A range of advanced wound care products, including foams, gels, and dressings, used to promote wound healing and tissue repair.

Resorba

A range of sutures and surgical meshes used in surgical procedures, including hernia repair, breast reconstruction, and orthopedic surgery.

8. Advanced Medical Solutions Group plc's Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for Advanced Medical Solutions Group plc is moderate due to the presence of alternative medical solutions and treatments available in the market.

Bargaining Power Of Customers

The bargaining power of customers is low due to the specialized nature of Advanced Medical Solutions Group plc's products and services, which limits the ability of customers to negotiate prices.

Bargaining Power Of Suppliers

The bargaining power of suppliers is moderate due to the presence of multiple suppliers in the market, but Advanced Medical Solutions Group plc's dependence on a few key suppliers limits its negotiating power.

Threat Of New Entrants

The threat of new entrants is low due to the high barriers to entry in the medical solutions industry, including regulatory hurdles and the need for significant investment in research and development.

Intensity Of Rivalry

The intensity of rivalry is high due to the presence of several established players in the medical solutions industry, leading to a competitive market with high marketing and advertising expenses.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 3.61%
Debt Cost 5.60%
Equity Weight 96.39%
Equity Cost 6.78%
WACC 6.73%
Leverage 3.74%

11. Quality Control: Advanced Medical Solutions Group plc passed 5 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Coltene

A-Score: 4.7/10

Value: 3.9

Growth: 2.7

Quality: 5.6

Yield: 8.1

Momentum: 2.0

Volatility: 5.7

1-Year Total Return ->

View Full Report
Stock-Card
Safilo

A-Score: 4.6/10

Value: 6.9

Growth: 3.7

Quality: 6.3

Yield: 0.0

Momentum: 8.5

Volatility: 2.0

1-Year Total Return ->

View Full Report
Stock-Card
Advanced Medical Solutions

A-Score: 3.8/10

Value: 3.0

Growth: 3.9

Quality: 5.2

Yield: 1.2

Momentum: 6.0

Volatility: 3.3

1-Year Total Return ->

View Full Report
Stock-Card
SKAN

A-Score: 3.6/10

Value: 0.6

Growth: 7.8

Quality: 5.8

Yield: 0.6

Momentum: 1.0

Volatility: 6.0

1-Year Total Return ->

View Full Report
Stock-Card
AddLife

A-Score: 3.6/10

Value: 1.5

Growth: 6.3

Quality: 4.1

Yield: 0.0

Momentum: 5.5

Volatility: 4.0

1-Year Total Return ->

View Full Report
Stock-Card
Tobii Dynavox

A-Score: 2.6/10

Value: 0.2

Growth: 5.2

Quality: 4.2

Yield: 0.0

Momentum: 4.0

Volatility: 2.0

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

2.26$

Current Price

2.26$

Potential

-0.00%

Expected Cash-Flows